LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)
Hong Kong
· Delayed Price · Currency is HKD 19.50
-0.60 (-2.99%)
May 16, 2025, 4:08 PM HKT
HKG:2291 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Operating Revenue | 471.14 | 325.9 | 247.67 | 222.58 | 148.25 | Upgrade
|
| Other Revenue | 0.5 | 0.73 | - | - | - | Upgrade
|
| Revenue | 471.64 | 326.62 | 247.67 | 222.58 | 148.25 | Upgrade
|
| Revenue Growth (YoY) | 44.40% | 31.88% | 11.27% | 50.14% | 27.30% | Upgrade
|
| Cost of Revenue | 47.61 | 37.53 | 27.98 | 25.04 | 15.13 | Upgrade
|
| Gross Profit | 424.03 | 289.09 | 219.69 | 197.55 | 133.11 | Upgrade
|
| Selling, General & Admin | 106.77 | 87.5 | 71.91 | 70.26 | 29.1 | Upgrade
|
| Research & Development | 57.99 | 62.07 | 53.87 | 41.39 | 38.96 | Upgrade
|
| Other Operating Expenses | -3.27 | -7.37 | -17.74 | -10.78 | -5.86 | Upgrade
|
| Operating Expenses | 168.47 | 136.21 | 113.72 | 101.8 | 61.05 | Upgrade
|
| Operating Income | 255.56 | 152.88 | 105.97 | 95.75 | 72.06 | Upgrade
|
| Interest Expense | -0.16 | -0.14 | -18.97 | -11.55 | -0.01 | Upgrade
|
| Interest & Investment Income | 28.84 | 25.58 | 5.67 | 7.85 | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.96 | -5.89 | -82.28 | 5.19 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.14 | 0.6 | -0.05 | 1.47 | -0.48 | Upgrade
|
| EBT Excluding Unusual Items | 286.06 | 173.04 | 10.34 | 98.72 | 71.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -4.93 | - | -0.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | - | - | - | 5.09 | Upgrade
|
| Asset Writedown | - | - | -0 | -0 | - | Upgrade
|
| Other Unusual Items | - | - | -20.44 | -32.69 | - | Upgrade
|
| Pretax Income | 286.09 | 173.04 | -15.03 | 66.03 | 76.68 | Upgrade
|
| Income Tax Expense | 40.53 | 21.66 | 4.78 | 7.33 | 7.91 | Upgrade
|
| Net Income | 245.56 | 151.38 | -19.81 | 58.7 | 68.77 | Upgrade
|
| Net Income to Common | 245.56 | 151.38 | -19.81 | 58.7 | 68.77 | Upgrade
|
| Net Income Growth | 62.22% | - | - | -14.65% | 32.49% | Upgrade
|
| Shares Outstanding (Basic) | 347 | 347 | 328 | 304 | 277 | Upgrade
|
| Shares Outstanding (Diluted) | 347 | 347 | 328 | 304 | 277 | Upgrade
|
| Shares Change (YoY) | - | 5.86% | 7.79% | 9.63% | - | Upgrade
|
| EPS (Basic) | 0.71 | 0.44 | -0.06 | 0.19 | 0.25 | Upgrade
|
| EPS (Diluted) | 0.71 | 0.44 | -0.06 | 0.19 | 0.25 | Upgrade
|
| EPS Growth | 62.22% | - | - | -22.14% | 32.49% | Upgrade
|
| Free Cash Flow | 137.05 | 66.75 | 52.25 | 82.83 | 56.57 | Upgrade
|
| Free Cash Flow Per Share | 0.40 | 0.19 | 0.16 | 0.27 | 0.20 | Upgrade
|
| Dividend Per Share | 0.620 | 0.570 | - | - | - | Upgrade
|
| Dividend Growth | 8.77% | - | - | - | - | Upgrade
|
| Gross Margin | 89.91% | 88.51% | 88.70% | 88.75% | 89.79% | Upgrade
|
| Operating Margin | 54.19% | 46.81% | 42.79% | 43.02% | 48.61% | Upgrade
|
| Profit Margin | 52.06% | 46.35% | -8.00% | 26.37% | 46.39% | Upgrade
|
| Free Cash Flow Margin | 29.06% | 20.44% | 21.10% | 37.21% | 38.16% | Upgrade
|
| EBITDA | 276.89 | 158.89 | 117.99 | 103.88 | 77.71 | Upgrade
|
| EBITDA Margin | 58.71% | 48.65% | 47.64% | 46.67% | 52.42% | Upgrade
|
| D&A For EBITDA | 21.33 | 6.01 | 12.02 | 8.13 | 5.64 | Upgrade
|
| EBIT | 255.56 | 152.88 | 105.97 | 95.75 | 72.06 | Upgrade
|
| EBIT Margin | 54.19% | 46.81% | 42.79% | 43.02% | 48.61% | Upgrade
|
| Effective Tax Rate | 14.17% | 12.52% | - | 11.10% | 10.31% | Upgrade
|
| Revenue as Reported | 471.64 | 326.62 | - | - | - | Upgrade
|
| Advertising Expenses | 3.25 | 3.19 | - | - | - | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.